UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 83

Sortiert nach

A Modified Newcastle-Ottawa Scale for Assessment of Study Quality in Genetic Urological Research

European urology, 2021-03, Vol.79 (3), p.325-326

2021

Volltextzugriff (PDF)

Introducing the Metastatic Breast Cancer Project: a novel patient-partnered initiative to accelerate understanding of MBC

ESMO open, 2018, Vol.3 (7), p.e000452-e000452, Article e000452

Parry, Marina

2018

Volltextzugriff (PDF)

Genetics and Prognostication in Splenic Marginal Zone Lymphoma: Revelations from Deep Sequencing

Clinical cancer research, 2015-09, Vol.21 (18), p.4174-4183

2015

Volltextzugriff (PDF)

Genetic correlates of prostate cancer visibility (and invisibility) on multiparametric magnetic resonance imaging: it's time to take stock

BJU international, 2020-03, Vol.125 (3), p.340-342

2020

Volltextzugriff (PDF)

Whole exome sequencing identifies novel recurrently mutated genes in patients with splenic marginal zone lymphoma

PloS one, 2013-12, Vol.8 (12), p.e83244-e83244

2013

Volltextzugriff (PDF)

Genetic Landscape of Prostate Cancer Conspicuity on Multiparametric Magnetic Resonance Imaging: A Systematic Review and Bioinformatic Analysis

European urology open science (Online), 2020-07, Vol.20, p.37-47

2020

Volltextzugriff (PDF)

Genetic landscape of prostate cancer conspicuity on multiparametric MRI: a protocol for a systematic review and bioinformatic analysis

BMJ open, 2020-01, Vol.10 (1), p.e034611-e034611

2020

Volltextzugriff (PDF)

Accumulation of copy number alterations and clinical progression across advanced prostate cancer

Genome medicine, 2022-09, Vol.14 (1), p.102-102, Article 102

2022

Volltextzugriff (PDF)

Genomic Evaluation of Multiparametric Magnetic Resonance Imaging-visible and -nonvisible Lesions in Clinically Localised Prostate Cancer

European urology oncology, 2019-02, Vol.2 (1), p.1-11

2019

Volltextzugriff (PDF)

Low frequency mutations independently predict poor treatment-free survival in early stage chronic lymphocytic leukemia and monoclonal B-cell lymphocytosis

Haematologica (Roma), 2015-06, Vol.100 (6), p.e237

2015

Volltextzugriff (PDF)

Molecular analysis of single circulating tumour cells following long‐term storage of clinical samples

Molecular oncology, 2017-12, Vol.11 (12), p.1687-1697

2017

Volltextzugriff (PDF)

Discordant Haplotype Sequencing Identifies Functional Variants at the 2q33 Breast Cancer Risk Locus

Cancer research (Chicago, Ill.), 2016-04, Vol.76 (7), p.1916-1925

2016

Volltextzugriff (PDF)

Tumor evolution in non-small-cell lung cancer

ESMO open, 2018, Vol.3 (6), p.e000436-e000436, Article e000436

Parry, Marina

2018

Volltextzugriff (PDF)

Molecular mechanisms of plasminogen activation: bacterial cofactors provide clues

Trends in biochemical sciences (Amsterdam. Regular ed.), 2000-02, Vol.25 (2), p.53-59

2000

Volltextzugriff (PDF)

Hereditary Pancreatitis Caused by a Novel PRSS1 Mutation (Arg-122 â Cys) That Alters Autoactivation and Autodegradation of Cationic Trypsinogen

The Journal of biological chemistry, 2002-02, Vol.277 (7), p.5404-5410

2002

Volltextzugriff (PDF)

The crystal structure of the novel snake venom plasminogen activator TSV-PA: a prototype structure for snake venom serine proteinases

Structure (London), 1998-09, Vol.6 (9), p.1195-1206

1998

Volltextzugriff (PDF)

Mini‐plasmin found in the epithelial cells of bronchioles triggers infection by broad‐spectrum influenza A viruses and Sendai virus

European journal of biochemistry, 2001-05, Vol.268 (10), p.2847-2855

2001

Volltextzugriff (PDF)

Kinetic Mechanism for the Interaction of Hirulog with Thrombin

Biochemistry (Easton), 1994-12, Vol.33 (49), p.14807-14814

1994

Volltextzugriff (PDF)

Cleavage of the thrombin receptor: identification of potential activators and inactivators

Biochemical journal, 1996-11, Vol.320 ( Pt 1) (1), p.335-341

1996

Volltextzugriff (PDF)

Copy number profiles of primary tumors for risk stratification of advanced prostate cancer: A biomarker study embedded in the multicenter STAMPEDE trial

Journal of clinical oncology, 2021-05, Vol.39 (15_suppl), p.5021-5021

2021

Volltextzugriff (PDF)

Proliferation index and survival in men with prostate cancer starting long-term androgen deprivation therapy in the STAMPEDE clinical trial

Journal of clinical oncology, 2021-05, Vol.39 (15_suppl), p.5076-5076

2021

Volltextzugriff (PDF)

Copy number architectures define treatment-mediated selection of lethal prostate cancer clones

Nature communications, 2023-08, Vol.14 (1), p.4823-4823, Article 4823

2023

Volltextzugriff (PDF)

Targeted next-generation sequencing (tNGS) of metastatic castrate-sensitive prostate cancer (M1 CSPC): A pilot molecular analysis in the STAMPEDE multi-center clinical trial

Journal of clinical oncology, 2019-05, Vol.37 (15_suppl), p.5019-5019

2019

Volltextzugriff (PDF)

The ternary microplasmin-staphylokinase- microplasmin complex is a proteinase-cofactor- substrate complex in action

Nature structural biology, 1998-10, Vol.5 (10), p.917-923

1998

Volltextzugriff (PDF)

Multiregion expression profiling of prostate cancer from men randomized in the STAMPEDE trial: Stage I results of a multistage biomarker analysis

Journal of clinical oncology, 2020-02, Vol.38 (6_suppl), p.153-153

2020

Volltextzugriff (PDF)

1 – 25 von 83

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(79)
Mit Volltextzugriff
(77)

Publikationsform

Sprache

Englisch
(83)
Japanisch
(9)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

A Modified Newcastle-Ottawa Scale for Assessment of Study Quality in Genetic Urological Research

Introducing the Metastatic Breast Cancer Project: a novel patient-partnered initiative to accelerate understanding of MBC

Genetics and Prognostication in Splenic Marginal Zone Lymphoma: Revelations from Deep Sequencing

Genetic correlates of prostate cancer visibility (and invisibility) on multiparametric magnetic resonance imaging: it's time to take stock

Whole exome sequencing identifies novel recurrently mutated genes in patients with splenic marginal zone lymphoma

Genetic Landscape of Prostate Cancer Conspicuity on Multiparametric Magnetic Resonance Imaging: A Systematic Review and Bioinformatic Analysis

Genetic landscape of prostate cancer conspicuity on multiparametric MRI: a protocol for a systematic review and bioinformatic analysis

Accumulation of copy number alterations and clinical progression across advanced prostate cancer

Genomic Evaluation of Multiparametric Magnetic Resonance Imaging-visible and -nonvisible Lesions in Clinically Localised Prostate Cancer

Low frequency mutations independently predict poor treatment-free survival in early stage chronic lymphocytic leukemia and monoclonal B-cell lymphocytosis

Molecular analysis of single circulating tumour cells following long‐term storage of clinical samples

Discordant Haplotype Sequencing Identifies Functional Variants at the 2q33 Breast Cancer Risk Locus

Tumor evolution in non-small-cell lung cancer

Molecular mechanisms of plasminogen activation: bacterial cofactors provide clues

Hereditary Pancreatitis Caused by a Novel PRSS1 Mutation (Arg-122 â Cys) That Alters Autoactivation and Autodegradation of Cationic Trypsinogen

The crystal structure of the novel snake venom plasminogen activator TSV-PA: a prototype structure for snake venom serine proteinases

Mini‐plasmin found in the epithelial cells of bronchioles triggers infection by broad‐spectrum influenza A viruses and Sendai virus

Kinetic Mechanism for the Interaction of Hirulog with Thrombin

Cleavage of the thrombin receptor: identification of potential activators and inactivators

Copy number profiles of primary tumors for risk stratification of advanced prostate cancer: A biomarker study embedded in the multicenter STAMPEDE trial

Proliferation index and survival in men with prostate cancer starting long-term androgen deprivation therapy in the STAMPEDE clinical trial

Copy number architectures define treatment-mediated selection of lethal prostate cancer clones

Targeted next-generation sequencing (tNGS) of metastatic castrate-sensitive prostate cancer (M1 CSPC): A pilot molecular analysis in the STAMPEDE multi-center clinical trial

The ternary microplasmin-staphylokinase- microplasmin complex is a proteinase-cofactor- substrate complex in action

Multiregion expression profiling of prostate cancer from men randomized in the STAMPEDE trial: Stage I results of a multistage biomarker analysis

Suchergebnisse filtern